General
|
RAC |
Re:
General Comments / Chat
|
|
21391401
|
11K |
3.9M |
1 |
20/08/24 |
20/08/24 |
General
|
11K
|
3.9M
|
1
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
21391401
|
11K |
3.9M |
7 |
19/08/24 |
19/08/24 |
General
|
11K
|
3.9M
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust - Media & News
|
|
21391401
|
111 |
38K |
5 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
111
|
38K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
21391401
|
248 |
67K |
2 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
248
|
67K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
21391401
|
207 |
52K |
5 |
11/08/24 |
11/08/24 |
ASX - By Stock
|
207
|
52K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
21391401
|
248 |
67K |
4 |
10/08/24 |
10/08/24 |
ASX - By Stock
|
248
|
67K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
21391401
|
248 |
67K |
7 |
10/08/24 |
10/08/24 |
ASX - By Stock
|
248
|
67K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
21391401
|
68 |
15K |
8 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
68
|
15K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
21391401
|
68 |
15K |
18 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
68
|
15K
|
18
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
21391401
|
978 |
265K |
9 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
978
|
265K
|
9
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
21391401
|
11K |
3.9M |
1 |
15/07/24 |
15/07/24 |
General
|
11K
|
3.9M
|
1
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
21391401
|
11K |
3.9M |
1 |
15/07/24 |
15/07/24 |
General
|
11K
|
3.9M
|
1
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
21391401
|
11K |
3.9M |
10 |
15/07/24 |
15/07/24 |
General
|
11K
|
3.9M
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
21391401
|
2.9K |
1.0M |
15 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
2.9K
|
1.0M
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Pipeline-in-a-drug
|
|
21391401
|
61 |
12K |
11 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
61
|
12K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Pipeline-in-a-drug
|
|
21391401
|
61 |
12K |
17 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
61
|
12K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor Webinar Presentation
|
|
21391401
|
7 |
2.7K |
2 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
7
|
2.7K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor Webinar Presentation
|
|
21391401
|
7 |
2.7K |
2 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
7
|
2.7K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust to test MPL effectiveness on Alzheimer's and Parkinson's
|
|
21391401
|
42 |
9.8K |
11 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
42
|
9.8K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
21391401
|
250 |
67K |
7 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
250
|
67K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
21391401
|
250 |
67K |
13 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
250
|
67K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
21391401
|
239 |
68K |
5 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
239
|
68K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
21391401
|
239 |
68K |
4 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
239
|
68K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
21391401
|
239 |
68K |
3 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
239
|
68K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
21391401
|
239 |
68K |
3 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
239
|
68K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
21391401
|
905 |
268K |
0 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
905
|
268K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
21391401
|
104 |
22K |
9 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
104
|
22K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
21391401
|
1.4K |
376K |
8 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1.4K
|
376K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
21391401
|
1.4K |
376K |
8 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1.4K
|
376K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
21391401
|
104 |
22K |
6 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
104
|
22K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
21391401
|
104 |
22K |
8 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
104
|
22K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
21391401
|
104 |
22K |
26 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
104
|
22K
|
26
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
21391401
|
104 |
22K |
19 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
104
|
22K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
21391401
|
104 |
22K |
3 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
104
|
22K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
21391401
|
261 |
76K |
9 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
76K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
21391401
|
261 |
76K |
7 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
76K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
21391401
|
261 |
76K |
5 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
76K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
21391401
|
261 |
76K |
5 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
76K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
21391401
|
261 |
76K |
8 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
76K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
21391401
|
261 |
76K |
11 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
76K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
21391401
|
261 |
76K |
10 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
76K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
21391401
|
1.4K |
376K |
27 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
1.4K
|
376K
|
27
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
21391401
|
1.4K |
376K |
6 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
1.4K
|
376K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
21391401
|
1.4K |
376K |
19 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
1.4K
|
376K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
21391401
|
66 |
19K |
6 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
66
|
19K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
21391401
|
66 |
19K |
6 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
66
|
19K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
21391401
|
66 |
19K |
10 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
66
|
19K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
21391401
|
66 |
19K |
13 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
66
|
19K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
21391401
|
66 |
19K |
16 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
66
|
19K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
21391401
|
63 |
20K |
5 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
63
|
20K
|
5
|
|